Access granted, now foreign vaccines must land up soon

Getting approval is only the first step. Getting these vaccines to the market fast will be the real challenge. From supply chain and cold storage logistics, to procurement, pricing and distribution, numerous aspects will need to be managed smoothly and swiftly.

Cos up paracetamol output as COVID lifts demand

The Indian pharmaceutical industry is scaling up production of paracetamol and azithromycin, as demand for the two drugs has risen following a sharp rise in COVID-19 cases, officials say.

Action against airlines for predatory pricing likely

The government is likely to take action against airlines that are found to engage in predatory pricing practices, says a senior official from the directorate general of civil aviation.

Access to bourse trade data will aid secular innovation

Data democracy is a must if innovations have to come from the grassroots, that is, from small- and medium-sized market participants. NSE's decision to open up its historical trade and orders data to researchers could well foster a culture of secular data analysis.

Kaushik Das sticks to 10.5% growth view for FY22

The resurgence in COVID-19 cases has experts warning of a bigger hit to the economy than expected earlier. Deutsche Bank AG's India Chief Economist Das, however, believes the bank's growth forecast of 10.5% for the current fiscal does not warrant any revision.

The news stories here are delayed and are representative of the range of our coverage. Live news first appears on the Cogencis Workstation.